John Schwartz - Stem Independent Chairman of the Board
| STEM Stock | USD 1.59 0.16 9.14% |
Chairman
Dr. John J. Schwartz Ph.D. is Independent Chairman of the Board of StemCells Inc. He is the former President and Chief Executive Officer of Systemix Inc. Dr. Schwartz is currently the President of Quantum Strategies Management Company a registered investment advisor located in Palo Alto California. Prior to his positions at Systemix he served as Assistant Professor Vice President and General Counsel at Stanford University in California since 1998.
| Age | 79 |
| Tenure | 26 years |
| Professional Marks | Ph.D |
| Address | 100 California Street, San Francisco, CA, United States, 94111 |
| Phone | 877 374 7836 |
| Web | https://www.stem.com |
Stem Management Efficiency
The company has return on total asset (ROA) of (0.0785) % which means that it has lost $0.0785 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2869) %, meaning that it created substantial loss on money invested by shareholders. Stem's management efficiency ratios could be used to measure how well Stem manages its routine affairs as well as how well it operates its assets and liabilities. As of the 15th of April 2024, Return On Tangible Assets is likely to grow to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.16. At this time, Stem's Net Tangible Assets are very stable compared to the past year. As of the 15th of April 2024, Non Current Assets Total is likely to grow to about 949.8 M, while Other Current Assets are likely to drop about 7.2 M.Similar Executives
| Found 9 records | CHAIRMAN Age | ||
| Jay Chaudhry | Zscaler | 59 | |
| Peter Thiel | Palantir TechnologiesInc | 57 | |
| Mark McLaughlin | Palo Alto Networks | 54 | |
| Owen Matthews | Uipath Inc | 42 | |
| Jagtar Chaudhry | Zscaler | 65 | |
| Daniel Dines | Uipath Inc | 52 | |
| Terence Matthews | Uipath Inc | 71 | |
| Matthew Prince | Cloudflare | 48 | |
| Nikesh Arora | Palo Alto Networks | 52 | |
Management Performance
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.0785 |
Stem Inc Leadership Team
Elected by the shareholders, the Stem's board of directors comprises two types of representatives: Stem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stem. The board's role is to monitor Stem's management team and ensure that shareholders' interests are well served. Stem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lisa Troe, Independent Director | ||
| Michael Morgan, Independent Director | ||
| Gregory Schiffman, CFO, Executive Vice President - Finance | ||
| Anil Tammineedi, Independent Director | ||
| Scott Greer, Independent Director | ||
| Ann Tsukamoto, Executive VP of Scientific and Strategic Alliances | ||
| Matt Tappin, VP Devel | ||
| Saul Laureles, Chief Legal Officer, Secretary | ||
| William CPA, Chief Officer | ||
| Mark Triplett, Chief Operating Officer | ||
| Robert Schaefer, President Initiatives | ||
| Rahul Shukla, Chief Officer | ||
| Martin McGlynn, CEO, Director, Member of Strategic Transactions Committee, CEO of Stemcells California Inc and President of Stemcells California Inc | ||
| Sylvia Lan, Vice President of Human Resources | ||
| Kenneth Stratton, General Counsel | ||
| Ricardo Levy, Independent Director | ||
| Larsh Johnson, Chief Technology Officer | ||
| John Carrington, Chief Executive Officer, Director | ||
| Alan Trounson, Director | ||
| Irving Weissman, Director | ||
| John Schwartz, Independent Chairman of the Board | ||
| Jane Woodward, Independent Director | ||
| William Bush, Chief Financial Officer | ||
| Ian Massey, President COO | ||
| Laura Tyson, Independent Director | ||
| Theodore Durbin, Head Relations | ||
| Bill Bush, Chief Financial Officer | ||
| Kim Homenock, Chief Officer | ||
| David Buzby, Independent Chairman of the Board | ||
| Mary Erotokritakis, Treasurer VP | ||
| Adam Daley, Independent Director | ||
| Michael Carlson, Chief Officer | ||
| Eric Bjerkholt, Independent Director | ||
| Alan Russo, Chief Revenue Officer | ||
| Prakesh Patel, Chief Strategy Officer | ||
| Brian Thompson, Founder |
Stem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Stem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.0785 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 699.55 M | ||||
| Shares Outstanding | 157.77 M | ||||
| Shares Owned By Insiders | 3.73 % | ||||
| Shares Owned By Institutions | 72.96 % | ||||
| Number Of Shares Shorted | 37.24 M | ||||
| Price To Earning | 10.62 X |
Currently Active Assets on Macroaxis
| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink | |
| XLM | Stellar | |
| CRO | Cronos |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Stem Inc information on this page should be used as a complementary analysis to other Stem's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Stem Stock analysis
When running Stem's price analysis, check to measure Stem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stem is operating at the current time. Most of Stem's value examination focuses on studying past and present price action to predict the probability of Stem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stem's price. Additionally, you may evaluate how the addition of Stem to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Stem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stem. If investors know Stem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share 2.966 | Quarterly Revenue Growth 0.077 | Return On Assets (0.08) | Return On Equity (0.29) |
The market value of Stem Inc is measured differently than its book value, which is the value of Stem that is recorded on the company's balance sheet. Investors also form their own opinion of Stem's value that differs from its market value or its book value, called intrinsic value, which is Stem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stem's market value can be influenced by many factors that don't directly affect Stem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.